Poland, March 11 -- Poland based IMED Poland Sp. z o.o. has secured contract from Instytut Matki i Dziecka for Various medicinal products Supply of the medicinal product Mifamurtide for a non-commercial clinical trial DRAGONFLY. The value of the contract is worth 99898200000 PLN.
Published by HT Digital Content Services with permission from Pivotal Sources....